RÉSUMÉ
Topoisomerase (Top) inhibitors used in clinical cancer treatments are limited because of their toxicity and severe side effects. Noteworthily, Top1/2 dual inhibitors overcome the compensatory effect between Top1 and 2 inhibitors to exhibit stronger antitumor efficacies. In this study, a series of indolo[3,2-c]isoquinoline derivatives were designed as Top1/2 dual inhibitors possessing apparent antiproliferative activities. Mechanistic studies indicated that the optimal compounds 23 and 31 with increasing reactive oxygen species levels damage DNA, inducing both cancer cell apoptosis and cycle arrest. Importantly, the results of the toxicity studies showed that compounds 23 and 31 possessed good oral safety profiles. In xenograft models, compound 23 exhibited remarkable antitumor potency, which was superior to the clinical Top inhibitors irinotecan and etoposide. Overall, this work highlights the therapeutic potential and safety profile of compound 23 as a Top1/2 dual inhibitor in tumor therapy and provides valuable lead compounds for further development of Top inhibitors.
Sujet(s)
Antinéoplasiques , ADN topoisomérases de type II , Isoquinoléines , Inhibiteurs de la topoisomérase-I , Inhibiteurs de la topoisomérase-II , Humains , Animaux , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Isoquinoléines/usage thérapeutique , Isoquinoléines/synthèse chimique , Isoquinoléines/pharmacocinétique , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Antinéoplasiques/usage thérapeutique , Antinéoplasiques/synthèse chimique , Inhibiteurs de la topoisomérase-II/pharmacologie , Inhibiteurs de la topoisomérase-II/usage thérapeutique , Inhibiteurs de la topoisomérase-II/composition chimique , Inhibiteurs de la topoisomérase-II/synthèse chimique , Inhibiteurs de la topoisomérase-I/pharmacologie , Inhibiteurs de la topoisomérase-I/usage thérapeutique , Inhibiteurs de la topoisomérase-I/composition chimique , Inhibiteurs de la topoisomérase-I/synthèse chimique , Administration par voie orale , ADN topoisomérases de type II/métabolisme , Lignée cellulaire tumorale , Relation structure-activité , Souris , Apoptose/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , ADN topoisomérases de type I/métabolisme , Tests de criblage d'agents antitumoraux , Tests d'activité antitumorale sur modèle de xénogreffe , Indoles/pharmacologie , Indoles/composition chimique , Indoles/usage thérapeutique , Souris nude , Découverte de médicament , Espèces réactives de l'oxygène/métabolismeRÉSUMÉ
The synthesized compound 1-(2-chlorophenyl) 6-7-dimethoxy-3-methyl-3,4-dihydroisoquinoline (DIQ) was investigated as a biological agent. Its potential to affect muscle contractility was predicted through in silico PASS analysis. Based on the in silico analysis, its capabilities were experimentally investigated. The study aimed to investigate the effects of DIQ on the ex vivo spontaneous contractile activity (CA) of smooth muscle (SM) tissue. DIQ was observed to reduce the strength of Ca2+-dependent contractions in SM preparations (SMP), possibly by increasing cytosolic Ca2+ levels through the activation of a voltage-gated L-type Ca2+ channel. DIQ potently affected calcium currents by modulating the function of muscarinic acetylcholine receptors (mAChRs) and 5-hydroxytryptamine (5-HT) receptors at a concentration of 50 µM. Immunohistochemical tests showed a 47% reduction in 5-HT2A and 5-HT2B receptor activity in SM cells and neurons in the myenteric plexus (MP), further confirming the effects of DIQ. Furthermore, a significant inhibition of neuronal activity was observed when the compound was co-administered with 5-HT to SM tissues. The conducted experiments confirm the ability of the isoquinoline analog to act as a physiologically active molecule to control muscle contractility and related physiological processes.
Sujet(s)
Isoquinoléines , Contraction musculaire , Muscles lisses , Animaux , Contraction musculaire/effets des médicaments et des substances chimiques , Muscles lisses/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Calcium/métabolisme , Récepteurs sérotoninergiques/métabolisme , Rats , Récepteur muscarinique/métabolisme , Mâle , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolismeRÉSUMÉ
Multidrug resistance (MDR) of human tumors has resulted in an immediate need to develop appropriate new drugs. This work outlines the development of 20 potent IQQ N-oxide derivatives in two isomeric families, both exhibiting nanomolar GI50 against human tumor cell lines. Preliminary NCI-60 tumor screening sees the C(6) isomers achieve a mean GI50 > 2 times lower than the corresponding C(7) isomers. MDR evaluation of nine selected compounds reveals that each presents lower GI50 concentrations in two MDR tumor cell lines. Four of the series display nanomolar GI50 values against MDR cells, having selectivity ratios up to 2.7 versus the sensitive (parental) cells. The most potent compound 25 inhibits the activity of drug efflux pumps in MDR cells, causes significant ROS accumulation, and potently inhibits cell proliferation, causing alterations in the cell cycle profile. Our findings are confirmed by 3D spheroid models, providing new candidates for studies against MDR cancers.
Sujet(s)
Antinéoplasiques , Prolifération cellulaire , Multirésistance aux médicaments , Résistance aux médicaments antinéoplasiques , Tests de criblage d'agents antitumoraux , Humains , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Antinéoplasiques/synthèse chimique , Cycle cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Découverte de médicament , Multirésistance aux médicaments/effets des médicaments et des substances chimiques , Résistance aux médicaments antinéoplasiques/effets des médicaments et des substances chimiques , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Isoquinoléines/synthèse chimique , Espèces réactives de l'oxygène/métabolisme , Relation structure-activité , Fluorescéines/synthèse chimique , Fluorescéines/composition chimique , Fluorescéines/pharmacologieRÉSUMÉ
Aptamers are good affinity receptors for bio-assays, while colorimetric method is suitable for point-of-care sensing via direct visualization. But previously aptamers often need complex re-engineering for colorimetric measurement at the cost of affinity and performance. Here isoquinoline alkaloids are found to own unique light-activated oxidative capacity, which can be specifically triggered by unmodified aptamers. This feature is universal for two alkaloids to efficiently oxidize four chromogenic substrates with obvious color changes. Based on a dye-displacement process, we have developed a novel light-activated aptamer system for the colorimetric assay of estradiol. It shows a good sensitivity with a detection limit of 326 nM, and this homogeneous assay is reliable to avoid artifacts in previous heterogeneous scheme. Besides, it is proven to be a universal design to assay other two targets. Significantly, they do not employ any aptamers re-engineering but only simply use their parental aptamers. Therefore, this light-activated oxidative capacity of isoquinoline alkaloid can serve as an ideal tool for colorimetric assay of various targets based on aptamer's specific recognition.
Sujet(s)
Alcaloïdes , Aptamères nucléotidiques , Colorimétrie , Isoquinoléines , Lumière , Oxydoréduction , Aptamères nucléotidiques/composition chimique , Colorimétrie/méthodes , Alcaloïdes/analyse , Alcaloïdes/composition chimique , Isoquinoléines/composition chimique , Isoquinoléines/analyse , Limite de détectionRÉSUMÉ
The novel bactericidal target-filamentous temperature-sensitive protein Z (FtsZ)-has drawn the attention of pharmacologists to address the emerging issues with drug/pesticide resistance caused by pathogenic bacteria. To enrich the structural diversity of FtsZ inhibitors, the antibacterial activity and structure-activity relationship (SAR) of natural sanguinarine and its analogs were investigated by using natural-products repurposing strategy. Notably, sanguinarine and chelerythrine exerted potent anti-Xanthomonas oryzae pv. oryzae (Xoo) activity, with EC50 values of 0.96 and 0.93 mg L-1, respectively, among these molecules. Furthermore, these two compounds could inhibit the GTPase activity of XooFtsZ, with IC50 values of 241.49 µM and 283.14 µM, respectively. An array of bioassays including transmission electron microscopy (TEM), fluorescence titration, and Fourier transform infrared spectroscopy (FT-IR) co-verified that sanguinarine and chelerythrine were potential XooFtsZ inhibitors that could interfere with the assembly of FtsZ filaments by inhibiting the GTPase hydrolytic ability of XooFtsZ protein. Additionally, the pot experiment suggested that chelerythrine and sanguinarine demonstrated excellent curative activity with values of 59.52% and 54.76%, respectively. Excitedly, these two natural compounds also showed outstanding druggability, validated by acceptable drug-like properties and low toxicity on rice. Overall, the results suggested that chelerythrine was a new and potential XooFtsZ inhibitor to develop new bactericide and provided important guiding values for rational drug design of FtsZ inhibitors. Notably, our findings provide a novel strategy to discover novel, promising and green bacterial compounds for the management of plant bacterial diseases.
Sujet(s)
Antibactériens , Protéines bactériennes , Benzophénanthridines , Protéines du cytosquelette , Isoquinoléines , Xanthomonas , Benzophénanthridines/pharmacologie , Benzophénanthridines/composition chimique , Antibactériens/pharmacologie , Antibactériens/composition chimique , Protéines bactériennes/antagonistes et inhibiteurs , Protéines bactériennes/métabolisme , Relation structure-activité , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Protéines du cytosquelette/antagonistes et inhibiteurs , Protéines du cytosquelette/métabolisme , Xanthomonas/effets des médicaments et des substances chimiques , Produits biologiques/pharmacologie , Produits biologiques/composition chimique , Tests de sensibilité microbienneRÉSUMÉ
BACKGROUND: Mini-chromosome maintenance protein 2 (MCM2) is a potential target for the development of cancer therapeutics. However, small molecule inhibitors targeting MCM2 need further investigation. METHODS: Molecular dynamics simulation was performed to identify active pockets in the MCM2 protein structure (6EYC). The active pocket was used as a docking model to discover MCM2 inhibitors by using structure-based virtual screening and surface plasmon resonance (SPR) assay. Furthermore, the efficacy of pixantrone targeting MCM2 in ovarian cancer was evaluated in vitro and in vivo. RESULTS: Pixantrone was identified as a novel inhibitor of MCM2 by virtual screening. SPR binding affinity analysis confirmed the direct binding of pixantrone to MCM2 protein. Pixantrone significantly reduced the viability of ovarian cancer cells A2780 and SKOV3 in a dose- and time-dependent manner. In addition, pixantrone inhibited DNA replication, and induced cell cycle arrest and apoptosis in ovarian cancer cells via targeting MCM2. Knockdown of MCM2 could attenuate the inhibitory activity of pixantrone in ovarian cancer cells. Furthermore, pixantrone significantly suppressed ovarian cancer growth in the A2780 cell xenograft mouse model and showed favorable safety. CONCLUSION: These findings suggest that pixantrone may be a promising drug for ovarian cancer patients by targeting MCM2 in the clinic.
Sujet(s)
Antinéoplasiques , Apoptose , Isoquinoléines , Composant-2 du complexe de maintenance des minichromosomes , Tumeurs de l'ovaire , Animaux , Femelle , Humains , Souris , Antinéoplasiques/pharmacologie , Antinéoplasiques/usage thérapeutique , Apoptose/effets des médicaments et des substances chimiques , Points de contrôle du cycle cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Réplication de l'ADN/effets des médicaments et des substances chimiques , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Isoquinoléines/usage thérapeutique , Souris nude , Composant-2 du complexe de maintenance des minichromosomes/métabolisme , Simulation de docking moléculaire , Tumeurs de l'ovaire/traitement médicamenteux , Tumeurs de l'ovaire/anatomopathologie , Tumeurs de l'ovaire/métabolisme , Tests d'activité antitumorale sur modèle de xénogreffeRÉSUMÉ
The fast spread of antibiotic resistance results in the requirement for a constant introduction of new candidates. Pentangular polyphenols, a growing family of actinomycetes-derived aromatic type II polyketides, have attracted considerable attention due to their intriguing polycyclic systems and potent antimicrobial activity. Among them, benastatins, anthrabenzoxocinones (ABXs), and fredericamycins, display unique variations in their polycyclic frameworks, yet concurrently share structural commonalities within their substitutions. The present review summarizes advances in the isolation, spectroscopic characteristics, biosynthesis, and biological activities of pentangular polyphenols benastatins (1-16), ABXs (17-39), and fredericamycins (40-42) from actinomycetes. The information presented here thus prompts researchers to further explore and discover additional congeners within these three small classes of pentangular polyphenols.
Sujet(s)
Antibactériens , Humains , Actinobacteria/métabolisme , Actinobacteria/composition chimique , Antibactériens/pharmacologie , Antibactériens/composition chimique , Antibactériens/biosynthèse , Antibactériens/synthèse chimique , Composés hétérocycliques avec 4 noyaux ou plus/composition chimique , Composés hétérocycliques avec 4 noyaux ou plus/pharmacologie , Tests de sensibilité microbienne , Structure moléculaire , Polyphénols/pharmacologie , Polyphénols/composition chimique , Relation structure-activité , Isoquinoléines/composition chimique , Isoquinoléines/pharmacologieRÉSUMÉ
While sanguinarine has gained recognition for antimicrobial and antineoplastic activities, its complex conjugated structure and low abundance in plants impede broad applications. Here, we demonstrate the complete biosynthesis of sanguinarine and halogenated derivatives using highly engineered yeast strains. To overcome sanguinarine cytotoxicity, we establish a splicing intein-mediated temperature-responsive gene expression system (SIMTeGES), a simple strategy that decouples cell growth from product synthesis without sacrificing protein activity. To debottleneck sanguinarine biosynthesis, we identify two reticuline oxidases and facilitated functional expression of flavoproteins and cytochrome P450 enzymes via protein molecular engineering. After comprehensive metabolic engineering, we report the production of sanguinarine at a titer of 448.64 mg L-1. Additionally, our engineered strain enables the biosynthesis of fluorinated sanguinarine, showcasing the biotransformation of halogenated derivatives through more than 15 biocatalytic steps. This work serves as a blueprint for utilizing yeast as a scalable platform for biomanufacturing diverse benzylisoquinoline alkaloids and derivatives.
Sujet(s)
Benzophénanthridines , Isoquinoléines , Génie métabolique , Saccharomyces cerevisiae , Température , Isoquinoléines/métabolisme , Isoquinoléines/composition chimique , Benzophénanthridines/métabolisme , Benzophénanthridines/biosynthèse , Saccharomyces cerevisiae/métabolisme , Saccharomyces cerevisiae/génétique , Génie métabolique/méthodes , Halogénation , Cytochrome P-450 enzyme system/métabolisme , Cytochrome P-450 enzyme system/génétiqueRÉSUMÉ
The total synthesis of 1,4a-di-epi-ent-pancratistatin, a novel stereoisomer of the anti-tumor Amaryllidaceae alkaloid pancratistatin, was achieved in 14 steps starting from D-mannitol. The construction of the pancratistatin skeleton involved conjugate addition of organocuprate to a nitrosoolefin, which was generated in situ from inosose oxime. This was followed by stereoselective reduction of the oxime to an amine and site-selective formylation. Biological evaluations revealed that the newly synthesized compounds exhibit cytotoxicity toward cancer cells and significant ferroptosis inhibitory activity. These compounds constitute a promising small-molecule library for the development of potent bioactive agents.
Sujet(s)
Alcaloïdes des Amaryllidaceae , Alcaloïdes des Amaryllidaceae/composition chimique , Alcaloïdes des Amaryllidaceae/pharmacologie , Alcaloïdes des Amaryllidaceae/synthèse chimique , Humains , Stéréoisomérie , Lignée cellulaire tumorale , Isoquinoléines/composition chimique , Isoquinoléines/pharmacologie , Isoquinoléines/synthèse chimique , Antinéoplasiques/pharmacologie , Antinéoplasiques/synthèse chimique , Antinéoplasiques/composition chimique , Tests de criblage d'agents antitumoraux , Structure moléculaire , Prolifération cellulaire/effets des médicaments et des substances chimiques , Relation structure-activité , Survie cellulaire/effets des médicaments et des substances chimiquesRÉSUMÉ
Bacteria have evolved resistance to nearly all known antibacterials, emphasizing the need to identify antibiotics that operate via novel mechanisms. Here we report a class of allosteric inhibitors of DNA gyrase with antibacterial activity against fluoroquinolone-resistant clinical isolates of Escherichia coli. Screening of a small-molecule library revealed an initial isoquinoline sulfonamide hit, which was optimized via medicinal chemistry efforts to afford the more potent antibacterial LEI-800. Target identification studies, including whole-genome sequencing of in vitro selected mutants with resistance to isoquinoline sulfonamides, unanimously pointed to the DNA gyrase complex, an essential bacterial topoisomerase and an established antibacterial target. Using single-particle cryogenic electron microscopy, we determined the structure of the gyrase-LEI-800-DNA complex. The compound occupies an allosteric, hydrophobic pocket in the GyrA subunit and has a mode of action that is distinct from the clinically used fluoroquinolones or any other gyrase inhibitor reported to date. LEI-800 provides a chemotype suitable for development to counter the increasingly widespread bacterial resistance to fluoroquinolones.
Sujet(s)
Antibactériens , DNA gyrase , Résistance bactérienne aux médicaments , Escherichia coli , Fluoroquinolones , Isoquinoléines , Sulfonamides , Inhibiteurs de la topoisomérase-II , Inhibiteurs de la topoisomérase-II/pharmacologie , Inhibiteurs de la topoisomérase-II/composition chimique , Inhibiteurs de la topoisomérase-II/synthèse chimique , Isoquinoléines/composition chimique , Isoquinoléines/pharmacologie , Isoquinoléines/synthèse chimique , Sulfonamides/pharmacologie , Sulfonamides/composition chimique , Sulfonamides/synthèse chimique , Fluoroquinolones/pharmacologie , Fluoroquinolones/composition chimique , Fluoroquinolones/synthèse chimique , DNA gyrase/métabolisme , Antibactériens/pharmacologie , Antibactériens/composition chimique , Antibactériens/synthèse chimique , Résistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/enzymologie , Tests de sensibilité microbienne , Relation structure-activité , Découverte de médicament , Régulation allostérique/effets des médicaments et des substances chimiquesRÉSUMÉ
Isoquinolinequinones represent an important family of natural alkaloids with profound biological activities. Heterologous expression of a rare bifunctional indole prenyltransferase/tryptophan indole-lyase enzyme from Streptomyces mirabilis P8-A2 in S. albidoflavus J1074 led to the activation of a putative isoquinolinequinone biosynthetic gene cluster and production of a novel isoquinolinequinone alkaloid, named maramycin (1). The structure of maramycin was determined by analysis of spectroscopic (1D/2D NMR) and MS spectrometric data. The prevalence of this bifunctional biosynthetic enzyme was explored and found to be a recent evolutionary event with only a few representatives in nature. Maramycin exhibited moderate cytotoxicity against human prostate cancer cell lines, LNCaP and C4-2B. The discovery of maramycin (1) enriched the chemical diversity of natural isoquinolinequinones and also provided new insights into crosstalk between the host biosynthetic genes and the heterologous biosynthetic genes in generating new chemical scaffolds.
Sujet(s)
Dimethylallyltransferase , Isoquinoléines , Streptomyces , Streptomyces/génétique , Streptomyces/métabolisme , Streptomyces/enzymologie , Humains , Dimethylallyltransferase/métabolisme , Dimethylallyltransferase/génétique , Lignée cellulaire tumorale , Isoquinoléines/composition chimique , Isoquinoléines/métabolisme , Isoquinoléines/pharmacologie , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Antinéoplasiques/métabolisme , Terpènes/métabolisme , Terpènes/composition chimique , Famille multigéniqueRÉSUMÉ
Naphthylisoquinoline alkaloids are a fascinating class of natural biaryl compounds. They show characteristic mono- and dimeric scaffolds, with chiral axes and stereogenic centers. Since the appearance of the last comprehensive overview on these secondary plant metabolites in this series in 1995, the number of discovered representatives has tremendously increased to more than 280 examples known today. Many novel-type compounds have meanwhile been discovered, among them naphthylisoquinoline-related follow-up products like e.g., the first seco-type (i.e., ring-opened) and ring-contracted analogues. As highlighted in this review, the knowledge on the broad structural chemodiversity of naphthylisoquinoline alkaloids has been decisively driven forward by extensive phytochemical studies on the metabolite pattern of Ancistrocladus abbreviatus from Coastal West Africa, which is a particularly "creative" plant. These investigations furnished a considerable number of more than 80-mostly new-natural products from this single species, with promising antiplasmodial activities and with pronounced cytotoxic effects against human leukemia, pancreatic, cervical, and breast cancer cells. Another unique feature of naphthylisoquinoline alkaloids is their unprecedented biosynthetic origin from polyketidic precursors and not, as usual for isoquinoline alkaloids, from aromatic amino acids-a striking example of biosynthetic convergence in nature. Furthermore, remarkable botanical results are presented on the natural producers of naphthylisoquinoline alkaloids, the paleotropical Dioncophyllaceae and Ancistrocladaceae lianas, including first investigations on the chemoecological role of these plant metabolites and their storage and accumulation in particular plant organs.
Sujet(s)
Alcaloïdes , Isoquinoléines , Humains , Alcaloïdes/composition chimique , Alcaloïdes/pharmacologie , Alcaloïdes/métabolisme , Isoquinoléines/composition chimique , Isoquinoléines/pharmacologie , Antinéoplasiques d'origine végétale/pharmacologie , Antinéoplasiques d'origine végétale/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Animaux , Structure moléculaireRÉSUMÉ
BACKGROUND: 6-Methoxydihydrosanguinarine (6-MDS) has shown promising potential in fighting against a variety of malignancies. Yet, its antilung adenocarcinoma (LUAD) effect and the underlying mechanism remain largely unexplored. This study sought to explore the targets and the probable mechanism of 6-MDS in LUAD through network pharmacology and experimental validation. METHODS: The proliferative activity of human LUAD cell line A549 was evaluated by Cell Counting Kit-8 (CCK8) assay. LUAD related targets, potential targets of 6-MDS were obtained from databases. Venn plot analysis were performed on 6-MDS target genes and LUAD related genes to obtain potential target genes for 6-MDS treatment of LUAD. The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database was utilized to perform a protein-protein interaction (PPI) analysis, which was then visualized by Cytoscape. The hub genes in the network were singled out by CytoHubba. Metascape was employed for GO and KEGG enrichment analyses. molecular docking was carried out using AutoDock Vina 4.2 software. Gene expression levels, overall survival of hub genes were validated by the GEPIA database. Protein expression levels, promotor methylation levels of hub genes were confirmed by the UALCAN database. Timer database was used for evaluating the association between the expression of hub genes and the abundance of infiltrating immune cells. Furthermore, correlation analysis of hub genes expression with immune subtypes of LUAD were performed by using the TISIDB database. Finally, the results of network pharmacology analysis were validated by qPCR. RESULTS: Experiments in vitro revealed that 6-MDS significantly reduced tumor growth. A total of 33 potential targets of 6-MDS in LUAD were obtained by crossing the LUAD related targets with 6-MDS targets. Utilizing CytoHubba, a network analysis tool, the top 10 genes with the highest centrality measures were pinpointed, including MMP9, CDK1, TYMS, CCNA2, ERBB2, CHEK1, KIF11, AURKB, PLK1 and TTK. Analysis of KEGG enrichment hinted that these 10 hub genes were located in the cell cycle signaling pathway, suggesting that 6-MDS may mainly inhibit the occurrence of LUAD by affecting the cell cycle. Molecular docking analysis revealed that the binding energies between 6-MDS and the hub proteins were all higher than - 6 kcal/Mol with the exception of AURKB, indicating that the 9 targets had strong binding ability with 6-MDS.These results were corroborated through assessments of mRNA expression levels, protein expression levels, overall survival analysis, promotor methylation level, immune subtypes andimmune infiltration. Furthermore, qPCR results indicated that 6-MDS can significantly decreased the mRNA levels of CDK1, CHEK1, KIF11, PLK1 and TTK. CONCLUSIONS: According to our findings, it appears that 6-MDS could possibly serve as a promising option for the treatment of LUAD. Further investigations in live animal models are necessary to confirm its potential in fighting cancer and to delve into the mechanisms at play.
Sujet(s)
Adénocarcinome pulmonaire , Tumeurs du poumon , Simulation de docking moléculaire , Pharmacologie des réseaux , Humains , Tumeurs du poumon/traitement médicamenteux , Adénocarcinome pulmonaire/traitement médicamenteux , Cellules A549 , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Cartes d'interactions protéiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Animaux , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , SourisRÉSUMÉ
The nanomaterialization of traditional Chinese medicine (TCM) has aroused widespread interest among researchers. Sanguinarine (SAN) is a kind of TCM with good antibacterial properties, which has important applications in anti-infection of wounds. Additionally, the combination of photothermal therapy and chemotherapy can overcome bacterial resistance, further improving bactericidal and wound healing efficiency. In this paper, we prepared an antibacterial agent by loading SAN on the zwitterion-modified MXene quantum dot nanocarrier (SAN@AHEP@Ta4C3), realizing pH/NIR controlled drug release and photothermal/chemotherapy synergistic antibacterial and wound healing. The particle size of SAN@AHEP@Ta4C3 is about 120 nm, and it has a good water solubility and stability. In addition, it also has excellent photothermal conversion performance (η = 39.2%), which can effectively convert light energy into heat energy under near-infrared (NIR) laser irradiation, further promoting drug release and achieving bactericidal effects by synergistic chemotherapy and photothermal therapy. The in vitro and in vivo experiments show that SAN@AHEP@Ta4C3 exhibits an excellent antibacterial effect against Staphylococcus aureus and Escherichia coli, and it can effectively promote the wound healing of mice. Moreover, the SAN@AHEP@Ta4C3 also has good biocompatibility and has no side effects on normal tissue and organs. This work introduces a multifunctional antibacterial agent based on TCM and hot-spot material MXene, which will have considerable application prospects in biomedical fields.
Sujet(s)
Antibactériens , Benzophénanthridines , Vecteurs de médicaments , Escherichia coli , Isoquinoléines , Boîtes quantiques , Staphylococcus aureus , Cicatrisation de plaie , Antibactériens/pharmacologie , Antibactériens/composition chimique , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Boîtes quantiques/composition chimique , Staphylococcus aureus/effets des médicaments et des substances chimiques , Animaux , Benzophénanthridines/composition chimique , Benzophénanthridines/pharmacologie , Escherichia coli/effets des médicaments et des substances chimiques , Souris , Vecteurs de médicaments/composition chimique , Isoquinoléines/composition chimique , Isoquinoléines/pharmacologie , Médecine traditionnelle chinoise , Thérapie photothermique , Libération de médicament , Tests de sensibilité microbienneRÉSUMÉ
Neuromuscular blocking agents (NMBAs) are widely used in anesthesia for intubation and surgical muscle relaxation. Novel atracurium and mivacurium derivatives were developed, with compounds 18c, 18d, and 29a showing mivacurium-like relaxation at 27.27 nmol/kg, and 15b, 15c, 15e, and 15h having a shorter duration at 272.7 nmol/kg. The structure-activity and configuration-activity relationships of these derivatives and 29a's binding to nicotinic acetylcholine receptors were analyzed through molecular docking. Rabbit trials showed 29a has a shorter duration compared to mivacurium. This suggests that linker properties, ammonium group substituents, and configuration are crucial for NMBA activity and duration, with compound 29a emerging as a potential ultra-short-acting NMBA.
Sujet(s)
Conception de médicament , Isoquinoléines , Curarisants , Curarisants/pharmacologie , Curarisants/synthèse chimique , Curarisants/composition chimique , Relation structure-activité , Animaux , Isoquinoléines/composition chimique , Isoquinoléines/pharmacologie , Isoquinoléines/synthèse chimique , Lapins , Récepteurs nicotiniques/métabolisme , Simulation de docking moléculaire , Structure moléculaire , Relation dose-effet des médicaments , Mivacurium , Atracurium/analogues et dérivés , Atracurium/pharmacologie , Atracurium/synthèse chimique , Atracurium/composition chimiqueRÉSUMÉ
Eleven undescribed isoquinoline alkaloids (1-8, 14, 15, and 24), along with 19 analogues (9-13, 16-23, and 25-30) were isolated from the barks of Alangium salviifolium. The structures of the undescribed compounds were elucidated through the analysis of their HR-ESI-MS, 1D and 2D NMR, IR, UV, and X-ray diffraction. The absolute configuration of 8 was established via the ECD calculation. Notably, compounds 1/2 and 3/4 were two pairs of C-14 epimers. The isolated alkaloids were evaluated for their cytotoxicity against various cancer cell lines, including SGC-7901, HeLa, K562, A549, BEL-7402, HepG2, and B16, ß-carboline-benzoquinolizidine (14-22) and cepheline-type (24-28) alkaloids exhibited remarkable cytotoxicity, with IC50 values ranging from 0.01 to 48.12 µM. Remarkably, compounds 17 and 21 demonstrated greater cytotoxicity than the positive control doxorubicin hydrochloride. Furthermore, a significant proportion of these bioactive alkaloids possess a C-1' epimer configuration. The exploration of their structure-activity relationship holds promise for directing future investigations into alkaloids derived from Alangium, potentially leading to novel insights and therapeutic advancements.
Sujet(s)
Alcaloïdes , Antinéoplasiques d'origine végétale , Tests de criblage d'agents antitumoraux , Isoquinoléines , Écorce , Humains , Alcaloïdes/composition chimique , Alcaloïdes/pharmacologie , Alcaloïdes/isolement et purification , Écorce/composition chimique , Isoquinoléines/composition chimique , Isoquinoléines/pharmacologie , Isoquinoléines/isolement et purification , Antinéoplasiques d'origine végétale/pharmacologie , Antinéoplasiques d'origine végétale/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Structure moléculaire , Relation structure-activité , Lignée cellulaire tumorale , Alangiaceae/composition chimique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicamentsRÉSUMÉ
REV-ERBα, a therapeutically promising nuclear hormone receptor, plays a crucial role in regulating various physiological processes such as the circadian clock, inflammation, and metabolism. However, the availability of chemical probes to investigate the pharmacology of this receptor is limited, with SR8278 being the only identified synthetic antagonist. Moreover, no X-ray crystal structures are currently available that demonstrate the binding of REV-ERBα to antagonist ligands. This lack of structural information impedes the development of targeted therapeutics. To address this issue, we employed Gaussian accelerated molecular dynamics (GaMD) simulations to investigate the binding pathway of SR8278 to REV-ERBα. For comparison, we also used GaMD to observe the ligand binding process of STL1267, for which an X-ray structure is available. GaMD simulations successfully captured the binding of both ligands to the receptor's orthosteric site and predicted the ligand binding pathway and important amino acid residues involved in the antagonist SR8278 binding. This study highlights the effectiveness of GaMD in investigating protein-ligand interactions, particularly in the context of drug recognition for nuclear hormone receptors.
Sujet(s)
Isoquinoléines , Membre-1 du groupe D de la sous-famille-1 de récepteurs nucléaires , Ligands , Membre-1 du groupe D de la sous-famille-1 de récepteurs nucléaires/métabolisme , Isoquinoléines/composition chimique , Thiophènes/composition chimique , Rythme circadien/physiologieRÉSUMÉ
Nine 3-arylisoquinoline alkaloids including five undescribed ones, hypectumines A-E (1-5), were isolated from the whole herb of Hypecoum erectum L. with the guidance of 1H-NMR. Their structures were established by a combination of 1D, 2D NMR, and HRESIMS spectrometry. Among them, hypectumines A and B possessed rare urea moieties while hypectumines C and D were characterized by 3-(methylamino)propanoic acid scaffolds. Biological assay demonstrated that alkaloids hypectumine B and 2,3-dimethoxy-N-formylcorydamine had anti-inflammatory effects by inhibiting NO production on LPS-induced RAW264.7 cells with IC50 values of 24.4 and 44.2 µM, respectively. Furthermore, hypectumine B could reduce the expression of pro-inflammatory cytokines TNF-α and IL-6, suggesting it might be a potential candidate for treating inflammatory disease.
Sujet(s)
Alcaloïdes , Lipopolysaccharides , Animaux , Souris , Alcaloïdes/pharmacologie , Alcaloïdes/composition chimique , Alcaloïdes/isolement et purification , Cellules RAW 264.7 , Lipopolysaccharides/pharmacologie , Lipopolysaccharides/antagonistes et inhibiteurs , Structure moléculaire , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/composition chimique , Anti-inflammatoires/isolement et purification , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Isoquinoléines/isolement et purification , Monoxyde d'azote/biosynthèse , Monoxyde d'azote/antagonistes et inhibiteurs , Facteur de nécrose tumorale alpha/métabolisme , Relation structure-activité , Interleukine-6/métabolisme , Relation dose-effet des médicaments , Spectroscopie par résonance magnétique du protonRÉSUMÉ
Nemertean worms contain toxins that are used to paralyze their prey and to deter potential predators. Hoplonemerteans often contain pyridyl alkaloids like anabaseine that act through nicotinic acetylcholine receptors and crustacean chemoreceptors. The chemical reactivity of anabaseine, the first nemertean alkaloid to be identified, has been exploited to make drug candidates selective for alpha7 subtype nAChRs. GTS-21, a drug candidate based on the anabaseine scaffold, has pro-cognitive and anti-inflammatory actions in animal models. The circumpolar chevron hoplonemertean Amphiporus angulatus contains a multitude of pyridyl compounds with neurotoxic, anti-feeding, and anti-fouling activities. Here, we report the isolation and structural identification of five new compounds, doubling the number of pyridyl alkaloids known to occur in this species. One compound is an isomer of the tobacco alkaloid anatabine, another is a unique dihydroisoquinoline, and three are analogs of the tetrapyridyl nemertelline. The structural characteristics of these ten compounds suggest several possible pathways for their biosynthesis.
Sujet(s)
Alcaloïdes , Isoquinoléines , Animaux , Alcaloïdes/pharmacologie , Alcaloïdes/composition chimique , Alcaloïdes/isolement et purification , Isoquinoléines/pharmacologie , Isoquinoléines/composition chimique , Isoquinoléines/isolement et purification , Invertébrés/composition chimique , Pyridines/pharmacologie , Pyridines/composition chimique , Pyridines/isolement et purification , Récepteurs nicotiniques/métabolisme , Récepteurs nicotiniques/effets des médicaments et des substances chimiques , Structure moléculaireRÉSUMÉ
Isoquinolone is one of the most common heterocyclic core structures in countless natural products and many bioactive compounds. Here, a highly efficient approach to synthesize isoquinolone scaffolds on DNA via rhodium(III)-catalyzed C-H activation has been described. This chemistry transformation is robust and has shown good compatibility with DNA, which is suitable for DNA-encoded library synthesis.